MONTRÉAL, 15 June, 2023 – CQDM – biopharmaceutical research consortium – is proud to announce the arrival of Carl Baillargeon within its team as Chief communications and marketing officer.
Carl Baillargeon is well known for his role as an Ambassador for life sciences, health technologies and innovation. For the past 20 years, he has consolidated and promoted growth within the ecosystems of life sciences, health technologies and innovation in Quebec and Canada. He has held several senior director positions in communications, marketing and public relations in large companies as well as in well-known organizations in the ecosystem. He currently holds positions as director, member of the executive and various committees on boards of directors. We invite you to consult his profile on CQDM’s website to learn more: https://cqdm.orgbiopharmaceutical-research-consortium-team/
“Carl, I am absolutely delighted to welcome you to the CQDM executive team. Your knowledge of the biopharmaceutical sector, LSHT and innovation, your dynamism and your expertise are major assets for the whole team. Also, your extended network in the ecosystem and various related bodies will bring to CQDM great initiatives promoting collaboration, research, and innovation in the ecosystem in Quebec and Canada! » said Diane Gosselin, President and CEO of CQDM.
About CQDM
CQDM is a biopharmaceutical research consortium whose mission is to fund the development of innovative technologies and tools to accelerate the discovery and development of safer and more effective drugs. It provides a hub where major global pharmaceutical companies, several Canadian biotechnology companies, the best researchers from the public and private sectors, as well as the governments of Quebec and Canada converge. CQDM’s collaborative approach allows it to meet the needs for innovation funding in the academic and private sectors, particularly in the early stages of research. Information – Website: cqdm.org, LinkedIn and Twitter.
For more information: info@cqdm.org
